LADENBURG THALMANN FINANCIAL SERVICES INC. - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 45 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$20,000214,917
+9143.7%
0.00%
Q2 2016$0
-100.0%
2,325
+75.5%
0.00%
Q1 2016$1,0000.0%1,3250.0%0.00%
Q4 2015$1,0000.0%1,3250.0%0.00%
Q3 2015$1,0000.0%1,3250.0%0.00%
Q2 2015$1,0000.0%1,3250.0%0.00%
Q1 2015$1,0000.0%1,3250.0%0.00%
Q4 2014$1,0000.0%1,3250.0%0.00%
Q3 2014$1,000
-91.7%
1,325
-90.7%
0.00%
Q2 2014$12,00014,2000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q2 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders